Motion Sickness Clinical Trials Motion Sickness RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
Condition:   Motion Sickness Interventions:   Drug: DPI-386 Nasal Gel;   Drug: DPI-386 Placebo Nasal Gel;   Drug: Transderm Scop® Sponsor:   Repurposed Therapeutics, Inc. Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2020 Category: Research Source Type: clinical trials